The top prescription drugs of 2012 globally: biologics dominate, but small molecule CNS drugs hold on to top spots

ACS Chem Neurosci. 2013 Jun 19;4(6):905-7. doi: 10.1021/cn400107y.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biological Products / therapeutic use*
  • Central Nervous System Agents / therapeutic use*
  • Drug Industry / statistics & numerical data
  • Drug Industry / trends*
  • Humans
  • Internationality
  • Prescription Drugs / therapeutic use*

Substances

  • Biological Products
  • Central Nervous System Agents
  • Prescription Drugs